Quick Summary

Schisandra chinensis is a traditional Chinese medicinal herb historically used for various health purposes. Scientific research, predominantly preclinical, suggests that Schisandra may have antioxidant, anti-inflammatory, hepatoprotective, adaptogenic, muscle structure supporting, and antiviral properties. Clinical evidence is limited and not definitive, with further high-quality human studies needed to validate efficacy and safety.

What is it?

Schisandra chinensis is a woody vine native to parts of Northeast Asia. It produces red berries often referred to as “five-flavor fruit” due to their complex taste profile. The plant has a long history of use in Traditional Chinese Medicine (TCM) for general health support.

Traditional Uses

Traditionally, Schisandra has been used in TCM to support liver health, enhance physical endurance, reduce fatigue, and improve mental performance. It is also employed as an adaptogen to help the body resist stress and maintain balance.

Active Compounds

Key bioactive constituents of Schisandra include lignans—particularly schisandrin B—which are believed to contribute to its pharmacological effects. Other compounds include antioxidants and anti-inflammatory agents that may underlie some of its observed activities in preclinical studies.

Potential Benefits with Evidence Levels

  • Hepatoprotective effects in liver injury
    Evidence Level: Preclinical systematic review and meta-analysis of 54 animal studies.
    Notes: Studies report significant reductions in liver injury markers (ALT, AST, ALP) and pro-inflammatory cytokines. Proposed mechanisms include antioxidant, anti-inflammatory, and anti-apoptotic effects. Clinical efficacy remains to be established.
  • Adaptogenic and stress-related benefits
    Evidence Level: Some clinical trials and mechanistic studies reviewed.
    Notes: Schisandrin B may stimulate molecular chaperones like Hsp70, modulate the HPA axis and stress signaling pathways, with small clinical studies indicating reductions in cortisol levels and fatigue.
  • Support in muscle atrophy
    Evidence Level: Preclinical meta-analysis of 11 animal studies.
    Notes: Observed improvements in muscle weight and antioxidant enzyme activity; functional benefits such as grip strength have not been confirmed; human data are lacking.
  • Effects on pharmacokinetics when combined with acupuncture at ST36 point
    Evidence Level: Preclinical studies.
    Notes: Acupuncture at the ST36 point enhances absorption and plasma concentration of Schisandra lignans; clinical implications require further study.
  • Potential antiviral activity
    Evidence Level: Preclinical in vitro and in vivo studies.
    Notes: Schisandrin B inhibited viral replication in fish models (e.g., rhabdovirus); clinical antiviral efficacy is unclear.
  • Modulation of gut microbiota in obesity
    Evidence Level: Limited clinical trials.
    Notes: Schisandra chinensis may modulate gut microbiota composition in obese individuals, though the impact on clinical outcomes was not statistically significant.

Side Effects

Available clinical safety data are limited but suggest good tolerability. No serious adverse events have been clearly attributed to Schisandra or formulas containing it. Commonly reported side effects are not well documented in available studies.

Drug Interactions

There is potential modulation of CYP3A4 and other drug-metabolizing enzymes based on pharmacokinetic studies. Caution is advised when Schisandra is used concomitantly with medications metabolized via these pathways. However, no high-quality clinical data on herb-drug interactions are currently available.

Who Should Avoid It

No specific contraindications have been documented in clinical evidence. Nevertheless, due to insufficient human safety data, caution is recommended. Schisandra use is not advised during pregnancy or breastfeeding unless under medical supervision.

Evidence Limitations

  • Most evidence originates from preclinical animal studies or limited clinical trials with small sample sizes and methodological limitations.
  • Lack of large-scale, randomized, double-blind, placebo-controlled clinical trials to confirm efficacy and safety.
  • Heterogeneity in herbal preparation standardization, dosing, and study designs reduces comparability.
  • Limited data on long-term safety and definitive herb-drug interaction profiles.
  • Uncertainty remains regarding the translation of preclinical mechanistic findings to clinical outcomes.

References

  • Huang BH et al. (2025). Efficacy of Schisandra chinensis in liver injury: a systematic review and preclinical meta-analysis. Frontiers in Pharmacology. PMID 40832608
  • Such S et al. (2026). System-Level, Molecular and Cellular Mechanisms of Selected Plant Adaptogens-A Review. Europe PMC. PMID 41901106
  • Liu X et al. (2026). Effects of schisandra extract on muscle atrophy: a systematic review and meta-analysis of preclinical studies. Frontiers in Pharmacology. PMID 41982662
  • Liu X et al. (2025). Mechanism, research progress and warning of the effects of acupuncture at Zusanli point (ST36) on pharmacokinetics: A review. Europe PMC. PMID 41261684
  • Cui S et al. (2025). Evaluating the clinical evidence of TCM in Alzheimer’s disease: an evidence map perspective. Europe PMC. PMID 40948654
  • Huang M et al. (2023). Changes in the Gut Microbiota after the Use of Herbal Medicines in Overweight and Obese Individuals: A Systematic Review. Nutrients. PMID 37432344
  • Liu Y et al. (2026). Evaluation of the Antiviral Activity of a Natural Product, Schisandrin B, Against Rhabdovirus Infection in Chinese Rice Field Eels. International Journal of Molecular Sciences. PMID 41596758
  • Liang CJW et al. (2025). Safety Considerations for Natural Products with Adaptogenic and Immunomodulating Activities. Pharmaceuticals. PMID 40872598

Last Reviewed

June 2024

Disclaimer: This information is for educational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting any new herbal supplement, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking other medications.